118 related articles for article (PubMed ID: 38940590)
21. NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS.
Elkins KL; Colombini SM; Krieg AM; De Pascalis R
Microbes Infect; 2009 Jan; 11(1):49-56. PubMed ID: 18992838
[TBL] [Abstract][Full Text] [Related]
22. GM-CSF has disparate roles during intranasal and intradermal Francisella tularensis infection.
Kurtz SL; Bosio CM; De Pascalis R; Elkins KL
Microbes Infect; 2016 Dec; 18(12):758-767. PubMed ID: 27475899
[TBL] [Abstract][Full Text] [Related]
23. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
Jia Q; Horwitz MA
Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
[No Abstract] [Full Text] [Related]
24. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
[TBL] [Abstract][Full Text] [Related]
25. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
Baron SD; Singh R; Metzger DW
Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
[TBL] [Abstract][Full Text] [Related]
26. Activities of Murine Peripheral Blood Lymphocytes Provide Immune Correlates That Predict Francisella tularensis Vaccine Efficacy.
De Pascalis R; Mittereder L; Kennett NJ; Elkins KL
Infect Immun; 2016 Apr; 84(4):1054-1061. PubMed ID: 26810039
[TBL] [Abstract][Full Text] [Related]
27. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response.
Barrigan LM; Tuladhar S; Brunton JC; Woolard MD; Chen CJ; Saini D; Frothingham R; Sempowski GD; Kawula TH; Frelinger JA
Infect Immun; 2013 Jun; 81(6):2028-42. PubMed ID: 23529616
[TBL] [Abstract][Full Text] [Related]
28. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
Dreisbach VC; Cowley S; Elkins KL
Infect Immun; 2000 Apr; 68(4):1988-96. PubMed ID: 10722593
[TBL] [Abstract][Full Text] [Related]
29. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
[TBL] [Abstract][Full Text] [Related]
30. Perforin- and granzyme-mediated cytotoxic effector functions are essential for protection against Francisella tularensis following vaccination by the defined F. tularensis subsp. novicida ΔfopC vaccine strain.
Sanapala S; Yu JJ; Murthy AK; Li W; Guentzel MN; Chambers JP; Klose KE; Arulanandam BP
Infect Immun; 2012 Jun; 80(6):2177-85. PubMed ID: 22493083
[TBL] [Abstract][Full Text] [Related]
31. Identification of Francisella tularensis live vaccine strain CuZn superoxide dismutase as critical for resistance to extracellularly generated reactive oxygen species.
Melillo AA; Mahawar M; Sellati TJ; Malik M; Metzger DW; Melendez JA; Bakshi CS
J Bacteriol; 2009 Oct; 191(20):6447-56. PubMed ID: 19684141
[TBL] [Abstract][Full Text] [Related]
32. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.
Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC
Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631
[TBL] [Abstract][Full Text] [Related]
33. Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.
Elkins KL; Colombini SM; Meierovics AI; Chu MC; Chou AY; Cowley SC
Microbes Infect; 2010 Jan; 12(1):28-36. PubMed ID: 19781659
[TBL] [Abstract][Full Text] [Related]
34. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
KuoLee R; Harris G; Conlan JW; Chen W
Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
[TBL] [Abstract][Full Text] [Related]
35. Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).
Twine SM; Petit MD; Fulton KM; House RV; Conlan JW
PLoS One; 2010 Apr; 5(4):e10000. PubMed ID: 20368994
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.
Kurtz SL; Foreman O; Bosio CM; Anver MR; Elkins KL
Infect Immun; 2013 Feb; 81(2):585-97. PubMed ID: 23230288
[TBL] [Abstract][Full Text] [Related]
37. Vaccine-Mediated Mechanisms Controlling
Lindgren H; Eneslätt K; Golovliov I; Gelhaus C; Rydén P; Wu T; Sjöstedt A
Pathogens; 2020 Apr; 9(5):. PubMed ID: 32365846
[No Abstract] [Full Text] [Related]
38. The live vaccine strain of Francisella tularensis replicates in human and murine macrophages but induces only the human cells to secrete proinflammatory cytokines.
Bolger CE; Forestal CA; Italo JK; Benach JL; Furie MB
J Leukoc Biol; 2005 Jun; 77(6):893-7. PubMed ID: 15758077
[TBL] [Abstract][Full Text] [Related]
39. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
Ray HJ; Cong Y; Murthy AK; Selby DM; Klose KE; Barker JR; Guentzel MN; Arulanandam BP
Clin Vaccine Immunol; 2009 Apr; 16(4):444-52. PubMed ID: 19211773
[TBL] [Abstract][Full Text] [Related]
40. Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.
Cole LE; Elkins KL; Michalek SM; Qureshi N; Eaton LJ; Rallabhandi P; Cuesta N; Vogel SN
J Immunol; 2006 Jun; 176(11):6888-99. PubMed ID: 16709849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
